Stockreport

Syros Pharmaceuticals Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$1.43 loss in 3Q 2023) [Yahoo! Finance]

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 81% p.a. on average during the next 3 years [Read more]